Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran

Polish Journal of Microbiology

Volumn 57, Issue 3, 2008, Pages 193-198

  Farshad, Shohreh ^a   Japoni, Aziz ^a   Hosseini, Marzieh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic sensitivity; Escherichia coli; Integron; Urinary tract infections

Indexed keywords

AMIKACIN; AMPICILLIN; CEFIXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; TETRACYCLINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISK DIFFUSION; GENE CASSETTE; HUMAN; INFANT; INTEGRON; IRAN; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSPOSON; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE TRANSFER, HORIZONTAL; HUMANS; INFANT; INTEGRONS; IRAN; MALE;

ESCHERICHIA COLI;

EID: 55049102351     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adwan K., N. Abu-Hasan, G. Adwan, N. Jarrar, B. Abu-Shanab and M. Al-Masri. 2004. Molecular epidemiology of anti-biotic-resistant Escherichia coil isolated from hospitalized patients with urinary tract infections in Northern Palestine. Pol. J. Microbiol. 53: 23-26.
2. Chang L.L., T.M. Chang and C.Y. Chang. 2007. Variable gene cassette patterns of class 1 integron-associated drug-resistant Escherichia coli in Taiwan. Kaohsiun. J. Med. Sci. 23: 273-280.
3. Clinical and Laboratory Standard Institute. 2006. Performance standards for antimicrobial susceptibility testing. M100-S16. Wayne, PA: CLSI.
4. Fluit AC. and F.J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur: J. Clin. Microbiol. Infect. Dis. 18: 761-770.
5. Gulsun S., N. Oguzoglu, A. Inan and N. Ceran. 2005. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Saudi. Med. J. 26: 1755-1758.
6. Japoni A., M. Gudarzi, SH. Farshad, E. Basiri, M. Ziyaeyan, A. Alborzi and N. Rafaatpour. 2008. Assay for integrons and pattern of antibiotic resistance in clinical Escherichia coli strains by PCR-RFLP in southern Iron. Jpn. J. Infect. Dis. 61: 85-88.
7. Johnson J. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4: 80-128.
8. Kahlmeter G. 2003. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int. J. Antimicrob Agents 2: 49-52.
9. Lee J.C., J.Y. Oh, J.W. Cho, J.C. Park, J.M. Kim, S.Y. Seol and D.T. Cho. 2001. The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coliin Korea. J. Antimicrob. Chemother. 47: 599-604.
10. Martinez-Freijo P., A.C. Fluit, F.J. Schmitz, V.S. Grek, J. Verhoef and M.E. Jones. 1998. Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J. Antimicrob. Chemother. 42: 689-696.
11. Mathai E., M. Grape and G. Kronvall. 2004. Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in southern India. APMIS 112: 159-164.
12. O'Brien T.F. 2002. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin. Infect. Dis. 34: 78-84.
13. Olsson-Liljequist B., P. Larsson, M. Walder and H. Miörner. 1997. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand. J. Infect. Dis. 105: 13-23.
14. Rao AN., M. Barlow, L.A. Clark, J.R. Boring, F.C. Tenover and J.E. McGowan. 2006. Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg. Infect. Dis. 12: 1011-1014.
15. Rijavec M., M. Starcic Erjavee, J. Ambrozic Avgustin, R. Reissbrodt, A. Fruth, V. Krizan-Hergouth and D. Zgur-Bertok. 2006. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr. Microbiol.53: 158-162.
16. Sallen B., A. Rajoharison, S. Desvarenne and C. Mabilat. 1995. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of Enterobacteriaceae. Microb. Drug Resist. 1: 195-202.
17. Sahm D.F., C. Thornsberry, D.C. Mayfield, M.E. Jones and J.A. Karlowsky. 2000. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother 45:1402-1406.
18. Solberg O.D., R.M. Ajiboye and L.W. Riley. 2006. Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli. J. Clin. Microbiol. 44: 1347-1351.
19. Svanborg C. and G. Godaly. 1997. Bacterial virulence in urinary tract infection. Infect. Dis. Clin. North. Am. 11: 513-521.
20. Tariq N., T. Jaffery, R. Ayub, A.Y. Alam, M.H. Javid and S. Shafique. 2006. Frequency and antimicrobial susceptibility of aerobic bacterial vaginal isolates. J. Coll. Physicians. Surg. Pak. 16: 196-199.
21. Vila J., K. Simon, J. Ruiz, J.P. Horcajada, M. Velasco, M. Barranco, A. Moreno and J. Mensa. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis. 186: 1039-1042.
22. White P.A., C.J. McIver and W.D. Rawlinson. 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob. Agents Chemother. 45: 2658-2661.
23. White P.A., C.J. McIver, Y. Deng and W.D. Rawlinson. 2000. Charaterisation of two new gene cassettes, aadA5 and dfrA17. FEMS Microbiol. Lett. 182: 265-269.
24. World Health Organization. 2001. WHO Global Strategy for Containment of Antimicrobial Resistance. 1-105. Geneva, Switzerland.
25. Yu H.S., J.C. Lee, H.Y. Kang, D.W. Ro, J.Y. Chung, Y.S. Jeong, S.H. Tae, C.H. Choi, E.Y. Lee, S.Y. Seol and others. 2003. Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades. J. Clin. Microbiol. 41: 5429-5433.